Antibody molecules for human IL-17

Details for Australian Patent Application No. 2007261748 (hide)

Owner AstraZeneca AB Cambridge Antibody Technology Ltd.

Inventors Welsh, Fraser; Russell, Caroline; Dufner, Patrick; Sleeman, Matthew; Langham, Caroline; Cochrane, Duncan; Needham, Maurice

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007261748

PCT Pub. Number WO2007/149032

Priority 60/815,828 23.06.06 US; 60/913,566 24.04.07 US

Filing date 20 June 2007

Wipo publication date 27 December 2007

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2007/149032 Priority application(s): WO2007/149032

7 May 2009 Alteration of Name

  The name of the applicant has been altered to AstraZeneca AB; MedImmune Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007261749-Substituted isoindoles as bace inhibitors and their use

2007261744-Advanced battery paster belt